August 24, 2016 8:23 PM ET

Biotechnology

Company Overview of Mesoblast Limited

Executive Profile

Jonathan Richard Symonds CBE, BA, FCA

Head of Corporate Finance & Strategy, Mesoblast Limited
AgeTotal Calculated CompensationThis person is connected to 5 Board Members in 5 different organizations across 12 different industries.

See Board Relationships
57--

Background

Mr. Jonathan Richard Symonds, also known as Jon, CBE, BA, FCA, serves as Head of Corporate Finance & Strategy at Mesoblast Limited. Mr. Symonds serves as Senior Advisor at GHO Capital Partners LLP. He serves as the Chief Financial Officer at Novartis Institutes for BioMedical Research, Inc. since September 1, 2009. He serves as Deputy Chief Financial Officer at Novartis Vaccines and Diagnostics, Inc. He joined Mesoblast as an advisor in 2014. He served as the Chief Financial ...

Corporate Headquarters

55 Collins Street
Melbourne, Victoria 3000

Australia

Phone: 61 3 9639 6036
Fax: 61 3 9639 6030

Board Members Memberships

Director
2014-Present
Independent Non-Executive Director, Chairman of Group Audit Committee and Member of Conduct & Values Committee
2014-Present
Chairman and Chairman of Chairman's Nominations & Remuneration Committee
2014-Present
Chairman
2016-Present
Chairperson, Member of Compensation Committee and Member of Nominating & Corporate Governance Committee

Education

BA 1980
University of Hertfordshire

Other Affiliations

Annual Compensation

There is no Annual Compensation data available.

Stocks Options

There is no Stock Options data available.

Total Compensation

There is no Total Compensation data available.
 

The information and data displayed in this profile are created and managed by Capital IQ, a Standard & Poor's company. Bloomberg.com does not create or control the content. For inquiries, please contact Capital IQ directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Gil Van Bokkelen Ph.D.Co-Founder, Chairman and Chief Executive Officer
Athersys, Inc.
$597.6K
Marc H. Hedrick M.D.Chief Executive Officer, President, Director and Member of Executive Committee
Cytori Therapeutics, Inc.
$450.0K
Zami Aberman Executive Chairman and Chief Executive Officer
Pluristem Therapeutics, Inc.
$465.3K
Christian Homsy M.D., MBAChief Executive Officer and Executive Director
Celyad SA
$579.0K
Compensation as of Fiscal Year 2015.

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Mesoblast Limited, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.